FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...
FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to support potential New Drug Application CervoMed is ...
But does starting Ozempic really throw off birth control? “I'm not aware of any publications that actually report changes in ...
QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in CashRepresents a 139.7% premium to most recent ...
Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company’s ongoing development initiatives Matthew ...
President Donald Trump said he is 'on it' after 'Dilbert' creator Scott Adams asked for help with prostate cancer treatment. Why is he controversial?
Drug developer Compass Pathways said on Tuesday it is pulling forward the expected launch timing of its experimental psilocybin-based depression therapy by 9 to 12 months. The decision follows the ...
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback